Key Segments:
By Type
-
Software
-
Services
By Method
-
Empirical Methods
-
Ab initio Methods
-
Others
By Application
-
Drug Discovery & Development
-
Diagnostics Development
-
Others
By End-use
-
Academic & Research
-
Industrial
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Thermo Fisher Scientific, Illumina, QIAGEN, Danaher, Bio-Techne, Charles River Laboratories, Eurofins, GenScript, MedGenome, and Twist Bioscience.
Key opportunities include clinical genomics and genetic testing expansion, genomic foundation models and AI-driven prediction, cloud-based annotation services, and emerging-market genomics programmes.
The market is driven by growing genomic data volumes, government support for genomics research, AI and machine learning integration, and rising demand for personalized medicine.
The Software segment dominated the Gene Prediction Tools Market, accounting for approximately 67% market share.
The North America region dominated the Gene Prediction Tools Market in 2025 with approximately 41.2% share, driven by strong genomics research infrastructure, substantial funding, and leading bioinformatics and AI companies.
